Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

Bio2RDF uri

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

http://bio2rdf.org/clinicaltrials:NCT00366899

Bio2RDF identifier

NCT00366899

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00366899

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00366899

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

605

http://www.w3.org/2001/XMLSchema#integer

brief summary [clinicaltrials_vocabulary:brief-summary]

The purpose of this stu ...... iatric vaccinations in Italy.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

http://www.w3.org/2001/XMLSchema#string

clinical result [clinicaltrials_vocabulary:clinical-result]

clinical results for clinicaltrials:NCT00366899 [clinicaltrials_resource:74273f066e25f86d001c29a1fc6fa5db]

clinicaltrials_vocabulary:other outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:other-outcome]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:062b8bdf36d4507a4a3210b91cae872c]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:68096bf661ef03de8fae3706fb283c8a]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:18d613e519c12e0676db59c0edec4115]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:3121bef184891512a6e930f99f46007c]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:49cf1e5f1503a66ae11a28b0b0ed2de8]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:6e674c6e99faec6982ed1719bce39220]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:78be4ec71d165847e89eb71042544752]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:a21f33fece21e68ba691ee3d84e7737c]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:a2ff57210bb4781dec8b390f57d29d31]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:dc9f2f5033d31aad6a4999cd4b5fe72d]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:f047ad33cec7cccc2ada78461ba2833a]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:fd64b9bdfbb37f67823e6fc639c6bb76]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:25dabb58d6ef4abce398c1656725821a]

Percentage of Participants Reporting Pre-Specified Local Reactions During the 4-day period after each dose [clinicaltrials_resource:2fae936d00214c7883f35fc81a874a03]

completion date [clinicaltrials_vocabulary:completion-date]

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Vaccines, Pneumococcal [clinicaltrials_resource:1453bd22a0648edd40258c4ee916657e]

country [clinicaltrials_vocabulary:country]

Italy [clinicaltrials_resource:1007e1b7f894dfbf72a0eaa80f3bc57e]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00366899 [clinicaltrials_resource:8ea4e9cb278535d7a9804a5d75d3a2f5]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2006-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]

2010-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

7 valent pneumococcal conjugate vaccine [clinicaltrials_resource:66e72d6abf1342f5cfc1051236b73489]

13-valent pneumococcal conjugate vaccine [clinicaltrials_resource:870665ce43ac531aee4cfa1f4ccd0b51]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

Yes

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Infants

http://www.w3.org/2001/XMLSchema#string

Vaccine

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2013-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Wyeth is now a wholly owned subsidiary of Pfizer [clinicaltrials_resource:20c6cf013f5d8e2c72b619b3d3dc7bf0]

location [clinicaltrials_vocabulary:location]

[clinicaltrials_resource:3b2a59797abb734b2c5af277c59ddcdf]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00366899

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Phase 3, Randomized, Active- ...... ediatric Vaccinations in Italy

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

6096A1-500

http://www.w3.org/2001/XMLSchema#string

outcome [clinicaltrials_vocabulary:outcome]

Percentage of Participants Reporting Pre-Specified Local Reactions [clinicaltrials_resource:NCT00366899/outcome/1]

overall official [clinicaltrials_vocabulary:overall-official]

Medical Monitor [clinicaltrials_resource:5f50f34d54468e0bf5c64acb56cce3e2]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Italy: Ethics Committee [clinicaltrials_resource:f0a89f10b08a6295743e9e08a6afc94d]

participant flow [clinicaltrials_vocabulary:participant-flow]

participant flow for clinicaltrials:NCT00366899 [clinicaltrials_resource:89e6d972fbeed7d9f4698195d89a14e6]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reported events [clinicaltrials_vocabulary:reported-events]

Reported events for NCT00366899 [clinicaltrials_resource:3154a7ac84ced6cd4d24276728ed5e21]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

Wyeth is now a wholly owned subsidiary of Pfizer [clinicaltrials_resource:20c6cf013f5d8e2c72b619b3d3dc7bf0]

start date [clinicaltrials_vocabulary:start-date]

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00366899 study design [clinicaltrials_resource:4d98657896deb81d73fc558fd4d70109]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00366899

verification date [clinicaltrials_vocabulary:verification-date]

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00366899

http://www.w3.org/2001/XMLSchema#string

title

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

@en